動画は、たっぷりとうるおいを閉じ込めたヒアルロン酸*配合のヒアレインSeptember 17, 2024
Eyedrops containing hyaluronic acid, "HiareinⓇS"
Santen Pharmaceuticals Co., Ltd. (Headquarters: Osaka City, hereinafter referred to as Santen) has appointed Jun Shison as the new brand ambassador for the general eye drops "HiareinⓇS," and will premiere a 15-second video on the brand's website starting on Tuesday, September 17, 2024. With outstanding acting skills in a wide range of roles and a gentle personality that captivates many people, Jun Shison, the new brand ambassador for HiareinⓇS, is considered capable of fully expressing the characteristic "moisturizing gentle world view" of HiareinⓇS.
"Experience, hyaluronic acid" section featuring a new video is also released on the brand's website.
- As the risk classification of over-the-counter drugs transitions to Category 2 pharmaceuticals, an expansion of sales outlets is planned -
*Sodium hyaluronate 0.1%
Santen Pharmaceuticals Co., Ltd. (Headquarters: Osaka City, hereinafter referred to as Santen) has appointed Jun Shison as the new brand ambassador for the general eye drops "HiareinⓇS," and will premiere a 15-second video on the brand's website starting on Tuesday, September 17, 2024. With outstanding acting skills in a wide range of roles and a gentle personality that captivates many people, Jun Shison, the new brand ambassador for HiareinⓇS, is considered capable of fully expressing the characteristic "moisturizing gentle world view" of HiareinⓇS.
In addition, the general use eye drops "HialineⓇS" was previously classified as a Class 1 pharmaceutical product, and could only be purchased through information provided in writing by a pharmacist. However, as of Monday, September 16, it has transitioned to a Class 2 pharmaceutical product with a risk classification. This means that in addition to pharmacists, it is now possible to consult and purchase at stores with registered sellers present, and there are expected to be more stores handling it in the future.
◇ [HialineⓇS] New Video "Reality, Hyaluronic Acid" Version
~ Video Content ~
The video portrays drops that encapsulate plenty of moisture with HialineⓇS, which contains hyaluronic acid, and showcases the close-up of Shisou-san's captivating eyes. The content aims to leave an impression of the product features that improve the lack of moisture, a factor leading to eye fatigue and haziness, guiding towards healthy eyes. Keeping the expression to a minimum, the video articulates the charming features of HialineⓇS with the clear and healthy eyes that tell a story, just as the saying goes, 'the eyes are the windows to the soul.'
* Sodium hyaluronate 0.1%
~ Video Shooting Episode ~
To create the drop scene for eye drops in CG, the reference video shooting was done with Shisou-san's own eyes. In the scene where drops fall into Shisou-san's eyes, due to camera positioning, the HialineⓇS had to be held slightly higher for instillation, leading to an unusual eye drop application style for Shisou-san, causing quite an anxious moment. The shoot, faced with tension by everyone, was successful, resulting in a visually stunning drop scene that could be mistaken for CG. The moment the video was viewed, cheers erupted on the set, and Shisou-san's eyes sparkled with excitement.
Video Publishing Platform
- 【Official Santen YouTube】
- 【Official HiareinⓇS Website】
◇Profile
Atsushi Shison
Born on March 5, 1995, in Tokyo. Made acting debut in 2011.
In 2014, he gained attention for his role as Tokkyu 1/Raito in the 38th Super Sentai series 'Ressha Sentai ToQger'. Awarded the 11th Confidence Award Drama Prize for Best Actor in a Leading Role and the Agency for Cultural Affairs Art Festival TV Drama Division Individual Broadcasting Award for his performance in the NHK Drama 10 'Joshi-teki Seikatsu'.
Recent notable works include NHK's continuous TV novel 'Ranman', TBS's Friday drama 'Fermer Cooking', Netflix series 'Yu Yu Hakusho', and the movie 'Whales of 52 Hertz'. In 2025, Netflix series 'Glass Heart' is scheduled for worldwide release.
◇HyalineⓇS Product Features
- Specially formulated with "purified sodium hyaluronate," a safe moisturizing ingredient produced in the body at 0.1%, this eye drop improves dryness caused by lack of moisture, one of the causes of eye symptoms such as eye fatigue, dryness, and blurriness.
- "Purified sodium hyaluronate" binds to mucin in tears (an ingredient responsible for retaining moisture on the surface of the eye), stays in the tear layer for a long time along with the enclosed water, and maintains tears stability.
- It is designed to be instilled while soft contact lenses (excluding color contact lenses) are worn.
◇HyalineⓇS Product Overview
| Product name | HyalineⓇS | |
| Classification | Pharmaceutical second-class | |
| Active ingredient | 0.1% Purified Sodium Hyaluronate | |
| Additives | Aminocaproic acid, Hydrated disodium ethylenediaminetetraacetate, Chlorhexidine gluconate solution, Isotonic agent, pH adjuster | |
| Efficacy/Effect | Relief of the following ocular symptoms: dryness, sensation of foreign body (feeling of rolling or stinging), fatigue, blurriness, discomfort when wearing soft or hard contact lenses | |
| Dosage/usage | Please administer one drop at a time, 5-6 times a day by applying eye drops. | |
| Precautions regarding usage and dosage | Please observe the following precautions. (1) When using with children, do so under the supervision and guidance of a guardian. (2) Do not let the tip of the container touch your eyes, eyelids, or eyelashes. (This may cause contamination or cloudiness of the medication due to the presence of eye discharge or bacteria). Also, do not use if the solution is cloudy. (3) Use only for ophthalmic purposes. When wearing colored contact lenses, do not use. | |
| Manufacturer and distributor | Santen Pharmaceutical Co., Ltd. | |
| Packaging type | 5mL × 1 bottle | 5mL × 2 bottles |
| Manufacturer's Suggested Retail Price | 880 yen (Exclusive of tax) | 1,580 yen (excluding tax) |
| Product Image |  |  |
For product details, please check the 'HyalineⓇS Official Website.'
About Santen
Santen aims to contribute to the realization of people's 'Happiness with Vision' by providing valuable products and services to patients, consumers, and healthcare professionals worldwide in the ophthalmology field as a specialized company. Since its establishment, under the basic principle of 'Participating in Divine Work,' Santen has been pursuing the maintenance and enhancement of eye health for over 130 years. Currently, Santen globally conducts research and development, manufacturing, sales, and marketing activities of pharmaceuticals in the ophthalmology field, supporting the eye health of approximately 50 million people in over 60 countries and regions around the world. Our mission is to continue providing important value in the prevention, diagnosis, and treatment of eye diseases to patients and society through products and services created from ophthalmic expertise and patient perspectives that have not been provided before. To create a future where as many patients as possible can lead happy and fulfilling lives, we are committed to realizing a society where people around the world can experience happiness through 'seeing.'
For more details, please refer to our company's website.
- Contact information for inquiries from the press related to this matter -
"Santen Pharmaceutical HyalineⓇ S" PR Office (within Antil Corporation)
TEL: 03-5572-7375 FAX: 03-6685-5265
Email: santen_pr@vectorinc.co.jp
- Contact information for product inquiries -
Santen Pharmaceutical Co., Ltd. "Customer Service Office"
TEL: 0120-127-023
- Contact information for inquiries related to Santen -
Santen Pharmaceutical Co., Ltd. Corporate Communication
Email: communication@santen.com